tiprankstipranks
Gyre Therapeutics Inc (GYRE)
:GYRE
US Market

Gyre Therapeutics (GYRE) Technical Analysis

Compare
801 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Gyre Therapeutics Inc’s (GYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.01, suggesting Gyre Therapeutics Inc is a Buy.
Gyre Therapeutics Inc’s (GYRE) 20-Day exponential moving average is 11.61, while Gyre Therapeutics Inc’s (GYRE) share price is $11.6, making it a Sell.
Gyre Therapeutics Inc’s (GYRE) 50-Day exponential moving average is 11.65, while Gyre Therapeutics Inc’s (GYRE) share price is $11.6, making it a Sell.

Gyre Therapeutics (GYRE) Pivot Points

Mar 04, 2025, 05:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
10.87
11.01
11.31
11.45
11.75
11.89
12.19
Fibonacci
11.01
11.18
11.29
11.45
11.62
11.73
11.89
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Gyre Therapeutics (GYRE) Moving Averages

Mar 04, 2025, 05:13 PM
Period
Simple
Exponential
MA5
11.45Sell
11.47Sell
MA10
11.68Sell
11.56Sell
MA20
11.84Sell
11.61Sell
MA50
11.42Buy
11.65Sell
MA100
12.23Sell
12.01Sell
MA200
12.35Sell
12.79Sell
Gyre Therapeutics Inc’s (GYRE) 10-Day exponential moving average is 11.56, while Gyre Therapeutics Inc’s (GYRE) share price is $11.6, making it a Sell.
Gyre Therapeutics Inc’s (GYRE) 100-Day exponential moving average is 12.01, while Gyre Therapeutics Inc’s (GYRE) share price is $11.6, making it a Sell.
Gyre Therapeutics Inc’s (GYRE) stock price is $11.6 and Gyre Therapeutics Inc’s (GYRE) 50-day simple moving average is 11.42, creating a Buy signal.
Gyre Therapeutics Inc’s (GYRE) stock price is $11.6 and Gyre Therapeutics Inc’s (GYRE) 100-day simple moving average is 12.23, creating a Sell signal.
Gyre Therapeutics Inc’s (GYRE) stock price is $11.6 and Gyre Therapeutics Inc’s (GYRE) 200-day simple moving average is 12.35, creating a Sell signal.

Gyre Therapeutics (GYRE) Technical Indicators

Mar 04, 2025, 05:13 PM
Name
Value
Implied Action
RSI (14)
48.39
Neutral
STOCH (9,6)
46.21
Neutral
STOCHRSI (14)
45.77
Neutral
MACD (12,26)
-0.01
Buy
ADX (14)
17.30
Buy
Williams %R
-54.63
Buy
CCI (14)
-67.33
Neutral
ATR (14)
0.70
-
Ultimate Oscillator
42.99
Neutral
ROC
-4.03
Sell
Gyre Therapeutics Inc’s (GYRE) Relative Strength Index (RSI) is 48.39, creating a Neutral signal.
Gyre Therapeutics Inc’s (GYRE) Trend Strength Indicator (ADX) is 17.30, creating a Buy signal.
Gyre Therapeutics Inc’s (GYRE) Commodity Channel Index (CCI) is -67.33, creating a Neutral signal.
Gyre Therapeutics Inc’s (GYRE) Price Rate of Change (ROC) is -4.03, creating a Sell signal.

FAQ

Is GYRE a Buy, Hold, or Sell?
Based on GYRE’s technical indicators, GYRE is a Sell.
    What is GYRE’s RSI (14)?
    GYRE’s RSI (14) is 48.39, which suggests GYRE is a Neutral.
      What is GYRE’s MACD?
      GYRE’s MACD is -0.01, which suggests GYRE is a Buy.
        What is GYRE’s 5-day moving average?
        GYRE’s 5-day moving average is 11.45, which suggests GYRE is a Sell.
          What is GYRE’s 20-day moving average?
          GYRE 20-day moving average is 11.84, which suggests GYRE is a Sell.
            What is GYRE’s 50-day moving average?
            GYRE’s 50-day moving average is 11.42, which suggests GYRE is a Buy.
              What is GYRE’s 200-day moving average?
              GYRE’s 200-day moving average is 12.35, which suggests GYRE is a Sell.
                What is GYRE’s Williams % R (14)?
                GYRE’s Williams % R (14) is -54.63, which suggests GYRE is a Buy.
                  What is GYRE’s CCI (14)?
                  GYRE’s CCI (14) is -67.33, which suggests GYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis